Franziska Sotzny

Dr. Franziska Sotzny, is a post-doctorate researcher at the Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany.

Awards

 * 2017 Ramsay Award Program grant was awarded to a team comprised of Dr. Carmen Scheibenbogen and Dr. Franziska Sotzny of Charité Universitätsmedizin Berlin, sponsored by the Solve ME/CFS Initiative for researching immunometabolism of T cells and monocytes in ME/CFS.

EUROMENE
Dr. Sotzny is a participant of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Notable studies

 * 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies - (Full text)


 * 2020, Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome - (Full text)


 * 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease - (Full Text)
 * 2018, The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome (Full Text)


 * 2017, Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray -(Full Text)

Online presence

 * PubMed